These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
412 related articles for article (PubMed ID: 20081275)
1. [Erythropoietin treatment of infants with anaemia in the first three months of life]. Gołebiowska-Staroszczyk S; Matysiak M; Adamowicz-Salach A; Sobocińska-Mirska A; Szmydki-Baran A; Romiszewski M Med Wieku Rozwoj; 2009; 13(4):270-6. PubMed ID: 20081275 [TBL] [Abstract][Full Text] [Related]
2. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284 [TBL] [Abstract][Full Text] [Related]
3. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. Maier RF; Obladen M; Scigalla P; Linderkamp O; Duc G; Hieronimi G; Halliday HL; Versmold HT; Moriette G; Jorch G N Engl J Med; 1994 Apr; 330(17):1173-8. PubMed ID: 8139627 [TBL] [Abstract][Full Text] [Related]
4. Early treatment of premature infants with recombinant human erythropoietin. Messer J; Haddad J; Donato L; Astruc D; Matis J Pediatrics; 1993 Oct; 92(4):519-23. PubMed ID: 8414820 [TBL] [Abstract][Full Text] [Related]
5. Darbepoetin alfa effectively maintains haemoglobin concentrations at extended dose intervals relative to intravenous or subcutaneous recombinant human erythropoietin in dialysis patients. Brunkhorst R; Bommer J; Braun J; Haag-Weber M; Gill C; Wagner J; Wagener T; Nephrol Dial Transplant; 2004 May; 19(5):1224-30. PubMed ID: 14993489 [TBL] [Abstract][Full Text] [Related]
6. Recombinant human erythropoietin in the treatment of anemia of prematurity. Chen JY; Wu TS; Chanlai SP Am J Perinatol; 1995 Sep; 12(5):314-8. PubMed ID: 8540930 [TBL] [Abstract][Full Text] [Related]
7. Effects of vitamin E supplementation during erythropoietin treatment of the anaemia of prematurity. Pathak A; Roth P; Piscitelli J; Johnson L Arch Dis Child Fetal Neonatal Ed; 2003 Jul; 88(4):F324-8. PubMed ID: 12819167 [TBL] [Abstract][Full Text] [Related]
8. Potential for treatment of anaemia of prematurity with recombinant human erythropoietin: preliminary results. Phibbs RH; Shannon KM; Mentzer WC Acta Haematol; 1992; 87 Suppl 1():28-33. PubMed ID: 1574965 [TBL] [Abstract][Full Text] [Related]
9. Is the use of recombinant human erythropoietin in anaemia of prematurity cost-effective? Meyer MP; Haworth C; McNeill L S Afr Med J; 1996 Mar; 86(3):251-3. PubMed ID: 8658295 [TBL] [Abstract][Full Text] [Related]
10. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study. Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577 [TBL] [Abstract][Full Text] [Related]
11. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Fauchère JC; Dame C; Vonthein R; Koller B; Arri S; Wolf M; Bucher HU Pediatrics; 2008 Aug; 122(2):375-82. PubMed ID: 18676556 [TBL] [Abstract][Full Text] [Related]
12. The use of recombinant human erythropoietin in the treatment of anaemia of prematurity. Polkowska G; Wójcik-Skierucha E; Furmaga-Jabłońska W Ann Univ Mariae Curie Sklodowska Med; 2004; 59(2):178-83. PubMed ID: 16146073 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study. Arif B; Ferhan K Pediatr Int; 2005 Feb; 47(1):67-71. PubMed ID: 15693870 [TBL] [Abstract][Full Text] [Related]
14. [Evaluation of treatment results for anemia of prematurity treated with various doses of human recombinant erythropoietin]. Lauterbach R; Kachlik P; Pawlik D; Bajorek I Pediatr Pol; 1995 Sep; 70(9):739-44. PubMed ID: 8657506 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietin, protein, and iron supplementation and the prevention of anaemia of prematurity. Bechensteen AG; Hågå P; Halvorsen S; Whitelaw A; Liestøl K; Lindemann R; Grøgaard J; Hellebostad M; Saugstad OD; Grønn M Arch Dis Child; 1993 Jul; 69(1 Spec No):19-23. PubMed ID: 8346946 [TBL] [Abstract][Full Text] [Related]
16. Early erythropoietin influences both transfusion and ventilation need in very low birth weight infants. Tempera A; Stival E; Piastra M; De Luca D; Ottaviano C; Tramontozzi P; Marconi M; Cafforio C; Marcozzi P; Rossi N; Buffone E J Matern Fetal Neonatal Med; 2011 Aug; 24(8):1060-4. PubMed ID: 21250913 [TBL] [Abstract][Full Text] [Related]
17. [Randomized multi-center trial of the administration of erythropoietin in anemia of prematurity]. Javier Manchón G; Natal Pujol A; Coroleu Lletget W; Zuasnábar Cotro A; Badía Barnusell J; Juncá Piera J; Bel Comós J; Sábado Alvarez C; Prats Viñas J An Esp Pediatr; 1997 Jun; 46(6):587-92. PubMed ID: 9297428 [TBL] [Abstract][Full Text] [Related]
18. [Erythropoietin administration to preterm infants: comparison between subcutaneous and intravenous route]. Rigourd V; Kieffer F; Dommergues MA; Ayachi A; Assaf Z; Mohamed I; Voyer M; Magny JF Arch Pediatr; 2004 Apr; 11(4):319-26. PubMed ID: 15051090 [TBL] [Abstract][Full Text] [Related]
19. [Usefulness of erythropoietin in the treatment of anemia of prematurity. Influence of birth weight]. Carbonell Estrany X; Figueras Aloy J; Pérez Fernández JM; Fernández López A; González Luis G; Salvía Roiges MD An Esp Pediatr; 1999 Sep; 51(3):281-6. PubMed ID: 10575752 [TBL] [Abstract][Full Text] [Related]
20. Comparison of 2 iron doses in infants receiving recombinant human erythropoietin therapy. Nazir S; Peverini RL; Deming DD; Hopper AO; Vyhmeister NR Arch Pediatr Adolesc Med; 2002 Jun; 156(6):540-4. PubMed ID: 12038884 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]